Contact
Please use this form to send email to PR contact of this press release:
2nd Confirmation of Useful Data in Development of mRNA for Treating Cancer: Regen BioPharma, (Stock Symbols: RGBP) $RGBP
TO:
David R. Koos, Ph.D.
Regen BioPharma Inc.
+1 619-722-5505